Systematic review and meta-analysis of association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss: an update
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Systematic review and meta-analysis of association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss: an update ; volume:22 ; number:1 ; day:28 ; month:5 ; year:2024 ; pages:1-12 ; date:12.2024
Thrombosis journal ; 22, Heft 1 (28.5.2024), 1-12, 12.2024
- Urheber
-
Maghsudlu, Mohaddese
Noroozi, Zahra
Zokaei, Elham
Motevaseli, Elahe
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12959-024-00612-9
- URN
-
urn:nbn:de:101:1-2408060953344.451732284218
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maghsudlu, Mohaddese
- Noroozi, Zahra
- Zokaei, Elham
- Motevaseli, Elahe
- SpringerLink (Online service)
Ähnliche Objekte (12)
Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients
P2.03 The Plasminogen Activator Inhibitor-1 (4G/5G) Polymorphism Affects Central Arterial Blood Pressure in Women
Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
Towards secure 4G and 5G access network protocols
Der 4G/5G-PAI-1-Polymorphismus beim primären Mammakarzinom
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Die Bedeutung des 4G/5G-PAI-1-Promotorpolymorphismus beim Ovarialkarzinom
Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism
Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients
P2.03 The Plasminogen Activator Inhibitor-1 (4G/5G) Polymorphism Affects Central Arterial Blood Pressure in Women
Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
Towards secure 4G and 5G access network protocols
Der 4G/5G-PAI-1-Polymorphismus beim primären Mammakarzinom
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Die Bedeutung des 4G/5G-PAI-1-Promotorpolymorphismus beim Ovarialkarzinom
Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism
Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients
P2.03 The Plasminogen Activator Inhibitor-1 (4G/5G) Polymorphism Affects Central Arterial Blood Pressure in Women
Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
Towards secure 4G and 5G access network protocols
Der 4G/5G-PAI-1-Polymorphismus beim primären Mammakarzinom
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Die Bedeutung des 4G/5G-PAI-1-Promotorpolymorphismus beim Ovarialkarzinom